Avalo Therapeutics (AVTX) vs Faeth Therapeutics (FTH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Faeth Therapeutics (FTH) has outperformed Avalo Therapeutics (AVTX) over the past year, gaining 121.4% versus a gain of 0.7%. Over five years, FTH leads with a -83.7% price change compared with -99.8% for AVTX. Avalo Therapeutics is the larger company by market cap ($728.3 million vs $643.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVTX | FTH |
|---|---|---|
| Share price | $13.58 | $24.92 |
| Market cap | $728.30M | $643.94M |
| 1-day change | -0.07% | -7.33% |
| YTD return | -25.22% | +133.55% |
| 1-year return | +0.74% | +121.39% |
| 5-year return | -99.79% | -83.67% |
| EPS (TTM) | $-4.31 | $-60.86 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $24.27 | $42.14 |
| 52-week low | $12.51 | $7.45 |
| Distance from 52-week high | -44.05% | -40.87% |
| Average volume | 935.17K | 348.41K |
| Shares outstanding | 53.63M | 25.84M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- FTH has outperformed AVTX by 120.7 percentage points over the past year.
AVTX vs FTH FAQ
Which is bigger, Avalo Therapeutics or Faeth Therapeutics?
Avalo Therapeutics (AVTX) is larger, with a market capitalization of $728.30M compared with $643.94M for Faeth Therapeutics (FTH).
Which stock has performed better over the past year, AVTX or FTH?
FTH returned +121.39% over the past 12 months, compared with +0.74% for AVTX (price return, excluding dividends). Past performance does not predict future results.
Are Avalo Therapeutics and Faeth Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.